UniProt P09945
Hirudin variant-2 (P09945)
Hirudin variant-2 (UniProt P09945): 218 experimental structures and 1 predicted model on GenesisL1, 20 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P09945
- Protein
- Hirudin variant-2
- Experimental structures
- 218
- Predicted models
- 1
- Pockets
- 20 · 19 records with a druggable one
Structures
219 records of P09945 in the MolNFT archive: 218 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1A2C | Structure of thrombin inhibited by AERUGINOSIN298-A from a BLUE-GREEN ALGA | x-ray diffraction | I | — | — |
| 1A2C | Structure of thrombin inhibited by AERUGINOSIN298-a from a blue-green alga | x-ray diffraction | I | — | — |
| 1A46 | Thrombin complexed with hirugen and a beta-strand mimetic inhibitor | x-ray diffraction | I | — | — |
| 1A46 | Thrombin complexed with hirugen and a beta-strand mimetic inhibitor | x-ray diffraction | I | — | — |
| 1A4W | Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site | x-ray diffraction | I | — | — |
| 1A4W | Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site | x-ray diffraction | I | — | — |
| 1A5G | Human thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugen | x-ray diffraction | I | — | — |
| 1A5G | Human thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugen | x-ray diffraction | I | — | — |
| 1A61 | Thrombin complexed with a beta-mimetic thiazole-containing inhibitor | x-ray diffraction | I | — | — |
| 1A61 | Thrombin complexed with a beta-mimetic thiazole-containing inhibitor | x-ray diffraction | I | — | — |
| 1B5G | Human thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugen | x-ray diffraction | I | — | — |
| 1B5G | Human thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugen | x-ray diffraction | I | — | — |
| 1DOJ | Crystal structure of human alpha-thrombin*RWJ-51438 complex at 1.7 A | x-ray diffraction | B | — | — |
| 1DOJ | Crystal structure of human alpha-THROMBIN*RWJ-51438 complex at 1.7 a | x-ray diffraction | B | — | — |
| 1HGT | Structure of the hirugen and hirulog 1 complexes of alpha-thrombin | x-ray diffraction | I | — | — |
| 1HGT | Structure of the hirugen and hirulog 1 complexes of alpha- thrombin | x-ray diffraction | I | — | — |
| 1K21 | Human thrombin-inhibitor complex | x-ray diffraction | I | — | — |
| 1K21 | Human thrombin-inhibitor complex | x-ray diffraction | I | — | — |
| 1K22 | Human thrombin-inhibitor complex | x-ray diffraction | I | — | — |
| 1K22 | Human thrombin-inhibitor complex | x-ray diffraction | I | — | — |
| 1NRS | Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of… | x-ray diffraction | I | — | — |
| 1NRS | Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of… | x-ray diffraction | I | — | — |
| 1TBZ | Human thrombin with active site N-methyl-D phenylalanyl-N-[5-(AMINOIMINOMETHYL)AMINO]-1-{{BENZOTHIAZ… | x-ray diffraction | I | — | — |
| 1TBZ | Human thrombin with active site N-methyl-D phenylalanyl-N-[5… | x-ray diffraction | I | — | — |
| 1TMB | Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide… | x-ray diffraction | I | — | — |
| 1TMB | Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide… | x-ray diffraction | I | — | — |
| 1TMU | Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to… | x-ray diffraction | J | — | — |
| 1TMU | Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to… | x-ray diffraction | J | — | — |
| 1VZQ | Complex of thrombin with designed inhibitor 7165 | x-ray diffraction | I | — | — |
| 1VZQ | Complex of thrombin with designed inhibitor 7165 | x-ray diffraction | I | — | — |
| 1W7G | Alpha-thrombin complex with sulfated hirudin (residues 54-65) and L- Arginine template inhibitor… | x-ray diffraction | I | — | — |
| 1W7G | Alpha-thrombin complex with sulfated hirudin (residues 54-65) and L- arginine template inhibitor… | x-ray diffraction | I | — | — |
| 1WBG | Active site thrombin inhibitors | x-ray diffraction | I | — | — |
| 1WBG | Active site thrombin inhibitors | x-ray diffraction | I | — | — |
| 2BVR | Human thrombin complexed with fragment-based small molecules occupying the S1 pocket | x-ray diffraction | I | — | — |
| 2BVR | Human thrombin complexed with fragment-based small molecules occupying the S1 pocket | x-ray diffraction | I | — | — |
| 2BVS | Human thrombin complexed with fragment-based small molecules occupying the S1 pocket | x-ray diffraction | I | — | — |
| 2BVS | Human thrombin complexed with fragment-based small molecules occupying the S1 pocket | x-ray diffraction | I | — | — |
| 2BVX | Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker | x-ray diffraction | I | — | — |
| 2BVX | Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic P1-P2-linker | x-ray diffraction | I | — | — |
| 2BXT | Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker | x-ray diffraction | I | — | — |
| 2BXT | Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic P1-P2-linker | x-ray diffraction | I | — | — |
| 2BXU | Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker | x-ray diffraction | I | — | — |
| 2BXU | Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic P1-P2-linker | x-ray diffraction | I | — | — |
| 2C8W | thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C8W | Thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C8X | thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C8X | Thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C8Y | thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C8Y | Thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C8Z | thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C8Z | Thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C90 | thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C90 | Thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C93 | thrombin inhibitors | x-ray diffraction | I | — | — |
| 2C93 | Thrombin inhibitors | x-ray diffraction | I | — | — |
| 2ZFQ | Exploring thrombin S3 pocket | x-ray diffraction | I | — | — |
| 2ZFQ | Exploring thrombin S3 pocket | x-ray diffraction | I | — | — |
| 2ZFR | Exploring thrombin S3 pocket | x-ray diffraction | I | — | — |
| 2ZFR | Exploring thrombin S3 pocket | x-ray diffraction | I | — | — |
159 records more on the page itself.
Experiment against prediction
- 4UFD chain I against the predicted model P09945: TM-score 1.00, RMSD 0.02 Å
- 4HTC chain I against the predicted model P09945: TM-score 0.85, RMSD 1.45 Å
- 3HTC chain I against the predicted model P09945: TM-score 0.84, RMSD 1.52 Å
- 1VZQ chain I against the predicted model P09945: TM-score 0.81, RMSD 0.25 Å
- 1VZQ chain I against the predicted model P09945: TM-score 0.81, RMSD 0.25 Å
- 4LOY chain I against the predicted model P09945: TM-score 0.62, RMSD 0.54 Å
- 2C93 chain I against the predicted model P09945: TM-score 0.61, RMSD 0.53 Å
- 1TMU chain J against the predicted model P09945: TM-score 0.58, RMSD 0.54 Å
- 1TMU chain J against the predicted model P09945: TM-score 0.58, RMSD 0.54 Å
- 1TMB chain I against the predicted model P09945: TM-score 0.58, RMSD 0.65 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.